+420.1%
CORZ vs MRNA
+41.0%
+379.0%
-64.9%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for all.
| Period | Portfolio | MRNA | Excess | Alpha |
|---|---|---|---|---|
| 1D | -0.1% | -2.2% | +2.2% | 0.0% |
| 7D | +8.4% | +5.5% | +2.9% | +8.0% |
| 30D | -17.8% | +158.7% | -176.6% | -25.4% |
| 3M | -35.9% | +182.1% | -218.0% | -43.4% |
| 6M | +12.9% | +151.8% | -138.9% | +1.2% |
| YTD | +22.9% | +393.6% | -370.7% | -2.7% |
| 1Y | +31.4% | +499.5% | -468.1% | -0.3% |
| All | +420.1% | +41.0% | +379.0% | +359.5% |
Cumulative growth
Daily Returns
Daily percentage return beside MRNA.
Daily Out/Under-Performance
Portfolio return minus MRNA return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over all: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
all analysis · Full analysis span regression · 6 months rolling